L. Ritterhouse

发表

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

Lauren L. Ritterhouse, Catherine J. Wu, J. Garber, 2016, Oncotarget.

Current and historical hybridization with differential introgression among three species of cyprinid fishes (genus Cyprinella)

Lauren L. Ritterhouse, L. Ritterhouse, R. Broughton, 2011, Genetica.

Multi-Institutional Evaluation of Inter-rater Agreement of Variant Classification Based on the 2017 AMP, ASCO and CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.

Robert L Schmidt, Dara L Aisner, Susan J Hsiao, 2019, The Journal of molecular diagnostics : JMD.

Genomic Applications in Colorectal Carcinomas

Lauren L. Ritterhouse, W. Samowitz, L. Ritterhouse, 2018, Genomic Applications in Pathology.

Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing

Michelle N Wurst, Larissa V Furtado, Lauren L. Ritterhouse, 2019, Molecular Diagnosis & Therapy.

Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: A guide and case study in setting up an emergency-use, laboratory-developed molecular assay

Melis N. Anahtar, Pardis C Sabeti, Julie M. Batten, 2020, medRxiv.

60 kD Ro and nRNP A Frequently Initiate Human Lupus Autoimmunity

Lauren L. Ritterhouse, M. McClain, J. Harley, 2010, PloS one.

Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma

Cameron R. Smith, Lauren L. Ritterhouse, A. Iafrate, 2022, International journal of molecular sciences.

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center

Lauren L. Ritterhouse, Sabah Kadri, A. Husain, 2019, Oncotarget.

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma

Lauren L. Ritterhouse, J. Luke, T. Gajewski, 2019, Journal of Immunotherapy for Cancer.

Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression

Lauren L. Ritterhouse, A. D’Andrea, S. Rodig, 2017, Oncoimmunology.

Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus

Lauren L. Ritterhouse, J. Harley, J. Guthridge, 2011, Annals of the rheumatic diseases.

Melanotic Xp11 translocation renal cancer: report of a case with a unique intratumoral sarcoid-like reaction

Lauren L. Ritterhouse, M. Cykowski, L. Ritterhouse, 2014, Diagnostic Pathology.

Next generation sequencing identifies two Genomically distinct groups among pyloric gland adenomas.

Lauren L. Ritterhouse, Sabah Kadri, N. Niu, 2019, Human pathology.

Uterine PEComas: Correlation Between Melanocytic Marker Expression and TSC Alterations/TFE3 Fusions

Lauren L. Ritterhouse, C. Antonescu, E. Oliva, 2021, Modern Pathology.

Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing

Lauren L. Ritterhouse, Sabah Kadri, W. Stock, 2019, PloS one.

Molecular Biomarkers of Response to Cancer Immunotherapy.

Lauren L. Ritterhouse, L. Ritterhouse, T. Gogakos, 2022, Clinics in laboratory medicine.

Association of POLE-mutated and MSI endometrial cancers with an elevated number of tumor-infiltrating and peritumoral lymphocytes and higher expression of PD-L1.

A. D’Andrea, S. Rodig, U. Matulonis, 2015 .

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

Lauren L. Ritterhouse, G. Getz, S. Digumarthy, 2016 .

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

Lauren L. Ritterhouse, G. Getz, S. Digumarthy, 2016, Cancer discovery.

MET exon 14 Skipping Mutations: Essential Considerations for Current Management of Non-Small-Cell Lung Cancer.

K. Davies, Anthony N. Snow, L. Ritterhouse, 2022, The Journal of molecular diagnostics : JMD.

Recurrent Loss of Heterozygosity in Pancreatic Neuroendocrine Tumors

Lauren L. Ritterhouse, J. Hechtman, D. Klimstra, 2022, The American journal of surgical pathology.

A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor)

Lauren L. Ritterhouse, B. Weigelt, E. Oliva, 2021, The American journal of surgical pathology.

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

Jeffrey W. Clark, Lauren L. Ritterhouse, M. Rivera, 2022, The oncologist.

Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA

Lauren L. Ritterhouse, R. Berkowitz, L. Macconaill, 2017, Modern Pathology.

Clinicopathologic Evaluation and Molecular Profiling of Recurrent Stage IA Endometrial Endometrioid Carcinoma: A Case-control Study

Lauren L. Ritterhouse, G. Steinhardt, L. Ritterhouse, 2022, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2

Lauren L. Ritterhouse, D. Walt, P. Jarolim, 2021, BMC Infectious Diseases.

Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital

Melis N. Anahtar, Julie M. Batten, Lauren L. Ritterhouse, 2020, medRxiv.

Tumor mutational burden

Lauren L. Ritterhouse, L. Ritterhouse, 2019, Cancer cytopathology.

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.

Lauren L. Ritterhouse, D. Huo, Sabah Kadri, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Beyond the Variants: Mutational Patterns in Next-Generation Sequencing Data for Cancer Precision Medicine

Lauren L. Ritterhouse, L. Ritterhouse, M. Parilla, 2020, Frontiers in Cell and Developmental Biology.

Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

Lauren L. Ritterhouse, H. Hollema, C. V. van Asperen, 2019, Clinical Cancer Research.

Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.

Lauren L. Ritterhouse, Catherine J. Wu, S. Shukla, 2015, JAMA oncology.

Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations

Lauren L. Ritterhouse, Sushant A. Patil, Sabah Kadri, 2019, Journal of neuropathology and experimental neurology.

Tumor infiltrating and peritumoral T cells and expression of PD-L1 in BRCA1/2-mutated high grade serous ovarian cancers.

Lauren L. Ritterhouse, A. D’Andrea, S. Rodig, 2015 .

Institutional implementation of clinical tumor profiling on an unselected cancer population.

Marian Harris, Ethan Cerami, Frank C Kuo, 2016, JCI insight.

High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia

Lauren L. Ritterhouse, P. D. Dal Cin, G. Pinkus, 2019, American journal of hematology.

Acute appendicitis secondary to metastatic carcinoma of the breast: Case report and review of the literature

Lauren L. Ritterhouse, E. Winer, N. Ramaiya, 2015 .

Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors.

Lauren L. Ritterhouse, B. Howitt, L. Ritterhouse, 2016, Surgical pathology clinics.

GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas

Lauren L. Ritterhouse, A. Iafrate, M. Mino‐Kenudson, 2017, Modern Pathology.

Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Ca

Larissa V Furtado, Lauren L. Ritterhouse, S. Murray, 2020 .

Molecular Testing in Pediatric Oncology Practice

Jeremy P. Segal, Lauren L. Ritterhouse, L. Ritterhouse, 2018 .

Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases

Larissa V Furtado, Lauren L. Ritterhouse, A. Félix, 2019, Modern Pathology.

Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape.

Lauren L. Ritterhouse, M. Mino‐Kenudson, J. Lennerz, 2022, JCO precision oncology.

Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma

Lauren L. Ritterhouse, Sushant A. Patil, Sabah Kadri, 2019, Modern Pathology.

insiM: in silico Mutator Software for Bioinformatics Pipeline Validation of Clinical Next-Generation Sequencing Assays.

Sabah Kadri, Ibro Mujacic, Jeremy P. Segal, 2019, The Journal of molecular diagnostics : JMD.

Microsatellite Instability Testing and Therapy Implications

Lauren L. Ritterhouse, L. Ritterhouse, David B. Chapel, 2020, Advances in Molecular Pathology.

Follicular Thyroid Neoplasms

Lauren L. Ritterhouse, N. Cipriani, Sabah Kadri, 2020, The American journal of surgical pathology.

The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer

Lauren L. Ritterhouse, L. Ritterhouse, I. Dagogo-Jack, 2020, Translational lung cancer research.

The Molecular Pathology of Lung Cancer: Pre-analytic Considerations

Lauren L. Ritterhouse, L. Sholl, L. Ritterhouse, 2018 .

BRAF V600E mutation-specific antibody: A review.

Lauren L. Ritterhouse, J. Barletta, L. Ritterhouse, 2015, Seminars in diagnostic pathology.

Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations

Lauren L. Ritterhouse, W. Foulkes, E. Oliva, 2021, Modern Pathology.

Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations.

Lauren L. Ritterhouse, N. Smith, Sabah Kadri, 2018, JCO precision oncology.

Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis

Lauren L. Ritterhouse, N. Cipriani, Sabah Kadri, 2019, The American journal of surgical pathology.

B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.

Lauren L. Ritterhouse, J. Guthridge, J. Merrill, 2011, Arthritis and rheumatism.

Vitamin D Deficiency in a Multiethnic Healthy Control Cohort and Altered Immune Response in Vitamin D Deficient European-American Healthy Controls

Lauren L. Ritterhouse, H. Maecker, T. Scriba, 2014, PloS one.

Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma

Lauren L. Ritterhouse, Sushant A. Patil, T. Antic, 2019, The American journal of surgical pathology.

Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations?

Lauren L. Ritterhouse, Sushant A. Patil, T. Antic, 2018, The American journal of surgical pathology.

System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.

Jorge Andrade, Samuel L Volchenboum, Dara L Aisner, 2018, The Journal of molecular diagnostics : JMD.

BAP1-Mutated Clear Cell Renal Cell Carcinoma.

Lauren L. Ritterhouse, T. Antic, A. Gallan, 2020, American journal of clinical pathology.

Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML

Lauren L. Ritterhouse, J. Lennerz, I. Cree, 2023, Clinical chemistry and laboratory medicine.

Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma

Lauren L. Ritterhouse, M. Nucci, L. Sholl, 2016, The American journal of surgical pathology.

Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas

Lauren L. Ritterhouse, R. Berkowitz, L. Macconaill, 2016, Modern Pathology.

Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report.

Lauren L. Ritterhouse, E. Lengyel, L. Ritterhouse, 2020, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Lauren L. Ritterhouse, E. Winer, C. Hudis, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Slide-to-Slide Tissue Transfer and Array Assembly From Limited Samples for Comprehensive Molecular Profiling.

Lauren L. Ritterhouse, J. Lennerz, L. Ritterhouse, 2023, Laboratory investigation; a journal of technical methods and pathology.

Best Practices in Incorporating Biomarker Testing to Deliver Precision Therapy in Cancer

L. Ritterhouse, 2018 .

Mosaicism for receptor tyrosine kinase activation in a glioblastoma involving both PDGFRA amplification and NTRK2 fusion.

Lauren L. Ritterhouse, A. Iafrate, A. Stemmer-Rachamimov, 2021, The oncologist.